Search Immortality Topics:

Page 10,250«..1020..10,24910,25010,25110,252..10,26010,270..»


Charlie Promo – Video

Posted: January 8, 2013 at 4:41 pm


Charlie Promo
Charlie is a film that comments on the responsibilities of parenting for a child with autism. Pledge Your Support for this film at: http://www.indiegogo.com LIKE us on Facebook at: on.fb.me Follow on Twitter @Charlie_TheFilm Discover at: #Charlie_TheFilm LIKE Sunset Studios on Facebook at: on.fb.me Follow on Twitter @SunsetStudiosFL

By: SunsetStudiosFL

Read the rest here:
Charlie Promo - Video

Recommendation and review posted by Fredricko

Autism Awareness – Video

Posted: January 8, 2013 at 4:41 pm


Autism Awareness
The aim of this video is to raise awareness of autism. Many see people acting differently to themselves and think they #39;re strange and just walk away. Or they see the difference and don #39;t know how to handle it. Again they just walk away. People with autism are different in some respects, but then aren #39;t we all? They may not behave in the same way as our friends, but we shouldn #39;t ignore them. We need to grasp the difference and see the potential. One young boy James is able to focus relentlessly on a single subject. Even though his hand-eye coordination was poor his ability to focus and practice night and day meant that he rose to no 4 for his age at Speed Stacking. We just need to find out what they are good at and help them achieve great things, even if it #39;s not what we would do or are interested in. So embrace the difference, don #39;t walk away.

By: GracesSpace2

Link:
Autism Awareness - Video

Recommendation and review posted by Fredricko

Black Ops 2:Race to Nuclear medal | 30 Kill without dying #4 – Video

Posted: January 8, 2013 at 4:41 pm


Black Ops 2:Race to Nuclear medal | 30 Kill without dying #4
Hi whats up i hope you have enjoyed the game play if so please leave a like and sub all money off our vids goes to help people with autism

By: TeamNaSuk

View post:
Black Ops 2:Race to Nuclear medal | 30 Kill without dying #4 - Video

Recommendation and review posted by Fredricko

Black Ops 2:Race to Nuclear medal | 30 Kill without dying #4 – Video

Posted: January 8, 2013 at 4:41 pm


Black Ops 2:Race to Nuclear medal | 30 Kill without dying #4
Hi whats up i hope you have enjoyed the game play if so please leave a like and sub all money off our vids goes to help people with autism

By: TeamNaSuk

View post:
Black Ops 2:Race to Nuclear medal | 30 Kill without dying #4 - Video

Recommendation and review posted by Fredricko

BioTime Buys Geron’s Stem Cell Assets, Including hESC Clinical Trial

Posted: January 8, 2013 at 3:29 am

Geron Corp., which pioneered the first
clinical trial of an hESC therapy, today sold its stem cell
business to another San Francisco Bay Area firm whose two top
executives were once CEOs at Geron.

Michael West
BioTime photo
The total value of the complex deal was
not clear from the public statements released by Geron and the
acquiring firm, BioTime, Inc., of Alameda, but an unidentified
outside investor is adding $10 million to transaction.
In a telephone interview this evening,
Michael West, CEO of BioTime, said that as a result of the deal his
firm will hold 600 patents and patent applications involving stem
cells. He said the aggregation should help in attracting financial
interest in the firm and its efforts.
West founded Geron in 1990. BioTime
Acquistion Corp
., the BioTime subsidiary that is picking up the Geron
assets, is headed by Tom Okarma, who was Geron's CEO from 1999 to
2011.
After Okarma left the firm in 2011,
Geron abruptly jettisoned its stem cell business along with the
clinical trial. Geron has been looking since then for a buyer for the
assets.
Tom Okarma
Geron photo
Only a few months prior to the Geron
decision in 2011, the California stem cell agency had signed a $25
million loan agreement with Geron to support the clinical trial. The
company paid back with interest the amount of the loan that it had
received.
Information from the two companies did
not specify whether BioTime will begin seeking additional
participants in the clinical trial. Nor did BioTime indicate whether
it would seek additional funding from the state stem cell agency.
However, West said during the telephone
interview that he has an “open mind” about working with CIRM.
Last year, agency officials indicated an interest in continuing to
support the clinical trial. West said BioTime had already hired some
employees that were laid off by Geron, including its patent attorney.
He said that he hoped to reassemble at least part of Geron's now
scattered stem cell team.
According to the Geron press release,
when the deal is officially concluded in September, “it is
anticipated that Geron stockholders would own approximately 21% of
BAC, BioTime would own approximately 72%, and a private investor
would own approximately 7% after an additional $5 million investment
in BAC.”
For its new operations, BioTime has
leased space in Menlo Park that Geron once used for its stem cell
business.
Both firms are publicy traded.
BioTime's stock price closed at $3.45 today and had a 52-week high of
$6.35 and a low of $2.67. Geron closed at $1.60 and had a 52-week
high of $2.99 and a low of 91 cents.

Here is a link to an article in the San
Francisco Business Times
about the deal. Here are links to the
BioTime press release, a BioTime FAQ and the Geron press release.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/TBbR-z7OPWc/biotime-buys-gerons-stem-cell-assets.html

Recommendation and review posted by G. Smith

Characterization and genomic analysis of kraft lignin biodegradation by the beta-proteobacterium Cupriavidus basilensis B-8

Posted: January 8, 2013 at 12:00 am

Background:
Lignin materials are abundant and among the most important potential sources for biofuel production. Development of an efficient lignin degradation process has considerable potential for the production of a variety of chemicals, including bioethanol. However, lignin degradation using current methods is inefficient. Given their immense environmental adaptability and biochemical versatility, bacterial could be used as a valuable tool for the rapid degradation of lignin. Kraft lignin (KL) is a polymer by-product of the pulp and paper industry resulting from alkaline sulfide treatment of lignocellulose, and it has been widely used for lignin-related studies.
Results:
Beta-proteobacterium Cupriavidus basilensis B-8 isolated from erosive bamboo slips displayed substantial KL degradation capability. With initial concentrations of 0.5--6 g L-1, at least 31.3% KL could be degraded in 7 days. The maximum degradation rate was 44.4% at the initial concentration of 2 g L-1. The optimum pH and temperature for KL degradation were 7.0 and 30[degree sign]C, respectively. Manganese peroxidase (MnP) and laccase (Lac) demonstrated their greatest level of activity, 1685.3 U L-1 and 815.6 U L-1, at the third and fourth days, respectively. Many small molecule intermediates were formed during the process of KL degradation, as determined using GC-MS analysis. In order to perform metabolic reconstruction of lignin degradation in this bacterium, a draft genome sequence for C. basilensis B-8 was generated. Genomic analysis focused on the catabolic potential of this bacterium against several lignin-derived compounds. These analyses together with sequence comparisons predicted the existence of three major metabolic pathways: beta-ketoadipate, phenol degradation, and gentisate pathways.
Conclusion:
These results confirmed the capability of C. basilensis B-8 to promote KL degradation. Whole genomic sequencing and systematic analysis of the C. basilensis B-8 genome identified degradation steps and intermediates from this bacterial-mediated KL degradation method. Our findings provide a theoretical basis for research into the mechanisms of lignin degradation as well as a practical basis for biofuel production using lignin materials.Source:
http://www.biotechnologyforbiofuels.com/content/6/1/1

Recommendation and review posted by G. Smith


Page 10,250«..1020..10,24910,25010,25110,252..10,26010,270..»